Please provide your email address to receive an email when new articles are posted on . At least once a month I will receive an e-mail from a client wanting to be sure that he or she is billing ...

Which health screenings and exams are top priorities for you? If you’re like most adults, monitoring your weight, cholesterol, and blood pressure is probably part of your health care routine. But what ...

Which health screenings and exams are top priorities for you? If you’re like most adults, monitoring your weight, cholesterol, and blood pressure is probably part of your health care routine. But what ...

This spring, a rash of cases of a rare, but often fatal, form of cancer known as ocular melanoma was reported, with 50 individuals in North Carolina and Alabama diagnosed over a relatively short time ...

David Watson has worn glasses to correct nearsightedness the majority of his life, and had his vision checked regularly to make sure his prescription was up to date. But when his wife convinced him to ...

A lack of understanding of insurance benefits was the most common barrier in adherence to dilated eye examinations among patients with diabetes, according to a study in American Health & Drug Benefits ...

Felicia Corbray’s cancer battle began in November 2017 after she noticed a small flash of light in the periphery of her eye. “I thought I was hallucinating because I was overtired,” she says. “I’d ...

Medicare currently covers visual acuity screenings for patients at the time of enrollment, but a new study suggests dilated eye examination would be more cost effective, according to findings ...

CLEVELAND, Ohio-- At a recent eye exam, Carin Marks prepared for the dreaded retinal exam -- the one where the doctor uses eyedrops to dilate the eyes so much that it's hard to see well after -- by ...

A spray containing 1% tropicamide and 2.5% phenylephrine is as effective as standard eye drops for pupil dilation in children, according to a recent clinical trial.

Last month, I attended a conference for physicians presented by Dr. Jesse Berry, an associate professor of ophthalmology at USC and the director of the Ocular Oncology and the Retinoblastoma Programs ...